tailieunhanh - Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer

Triple-negative breast cancer (TNBC) constitutes 10–20% of breast cancers and is challenging to treat due to a lack of effective targeted therapies. Previous studies in TNBC cell lines showed in vitro growth inhibition when JQ1 or GSK2801 were administered alone, and enhanced activity when co-administered. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN